Lycera lycera.com


Public lists: Pharma Startups (4732)

Lycera is a biopharmaceutical company pioneering approaches to the discovery and development of oral medicines for treating autoimmune diseases. The company is targeting pathways to develop new classes of selective, oral immunomodulators for the treatment of patients with diseases such as rheumatoid arthritis, psoriasis and inflammatory bowel disease. Lycera's goal is to develop drug candidates with efficacy and safety profiles that change the treatment paradigm for patients with autoimmune dise...Show all

Lycera is a biopharmaceutical company pioneering approaches to the discovery and development of oral medicines for treating autoimmune diseases. The company is targeting pathways to develop new classes of selective, oral immunomodulators for the trea...Show all

Company (Alive / Active)

Phone: 734-764-4548

Fax:

2800 Plymouth Road
NCRC, Building 26
Ann Arbor, 48109
Michigan, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Lycera $86.9M Jun 22, 2015
See all 17 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Lycera Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
InterWest PartnersVenture CapitalMenlo Park, California, United StatesSeries B, Series A - II, Series A
ARCH Venture PartnersVenture CapitalChicago, Illinois, United StatesSeries B, Series A - II, Series A
ClarusVenture CapitalCambridge, Massachusetts, United StatesSeries B, Series A - II, Series A
EDF VenturesVenture CapitalAnn Arbor, Michigan, United StatesSeries A - II, Series A, Seed VC
Third Rock VenturesVenture CapitalBoston, Massachusetts, United StatesSeries B
See all 6 investors

Competitors

Company Status Description Investors
See all 17 competitors